Showing results (1181-1190 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|June 4, 2015
Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lungPeter E Hall, James Spicer, Sanjay Popat
Future Oncology (London, England)|July 23, 2015
Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and managementAlfredo Tartarone, Giuseppina Gallucci, Chiara Lazzari, et al.
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: an ongoing evolutionBradley J Petek, Chris Greenman, Joerg Herrmann, et al.
Future Oncology (London, England)|June 5, 2015
Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter studyJose Muñoz-Langa, Javier De Castro, Pere Gascó, et al.
Future Oncology (London, England)|August 18, 2016
Oncofertility in Japan: advances in research and the roles of oncofertility consortiaNao Suzuki
Future Oncology (London, England)|August 16, 2016
Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancerYing Han, Jing Wang, Liping Hong, et al.
Future Oncology (London, England)|February 7, 2018
High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancerChao Tian, Shijie Zhou, Cheng Yi
Future Oncology (London, England)|March 17, 2018
Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is moreDawei Chen, Xinyu Song, Yan Zhang, et al.
Future Oncology (London, England)|March 21, 2018
STK24 expression is modulated by DNA copy number/methylation in lung adenocarcinoma and predicts poor survivalNingyu Huang, Wenbo Lin, Xiuyu Shi, et al.
Future Oncology (London, England)|January 19, 2018
Minimally invasive adrenal surgery: virtue or vice?Jared S Winoker, David T Ahlborn, Olamide O Omidele, et al.
Pageof 452